Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators.

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.

PMID:
22572202
2.

Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators.

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

3.

Long-term clinical outcome of patients with prior myocardial infarction after palliative radiofrequency catheter ablation for frequent ventricular tachycardia.

O'Callaghan PA, Poloniecki J, Sosa-Suarez G, Ruskin JN, McGovern BA, Garan H.

Am J Cardiol. 2001 Apr 15;87(8):975-9; A4.

PMID:
11305989
4.

Limitations and late complications of third-generation automatic cardioverter-defibrillators.

Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, Brooks DR, McGovern B, Guy M, Torchiana DF, et al.

Circulation. 1995 Apr 15;91(8):2204-13.

5.

Electrocardiographic pseudo-infarct patterns after implantation of cardioverter-defibrillators.

Osswald S, Roelke M, O'Nunain SS, Trouton TG, Sosa Suarez GE, Perez IE, Torchiana D, McGovern BA, Garan H, Ruskin JN, et al.

Am Heart J. 1995 Feb;129(2):265-72.

PMID:
7832098
6.

Curative transcatheter radiofrequency current ablation for atrioventricular nodal reentry tachycardia.

Trouton TG, O'Nunain SS, Kim YH, Sosa-Suarez GE, Garan H, Ruskin JN.

Arch Intern Med. 1994 Jun 13;154(11):1226-31.

PMID:
8203990
7.

Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease.

Kim YH, Sosa-Suarez G, Trouton TG, O'Nunain SS, Osswald S, McGovern BA, Ruskin JN, Garan H.

Circulation. 1994 Mar;89(3):1094-102.

PMID:
8124795
8.

Pseudo-pacemaker syndrome following inadvertent fast pathway ablation for atrioventricular nodal reentrant tachycardia.

Kim YH, O'Nunain S, Trouton T, Sosa-Suarez G, Levine RA, Garan H, Ruskin JN.

J Cardiovasc Electrophysiol. 1993 Apr;4(2):178-82.

PMID:
8269289
9.

Permanent AV block or modification of AV nodal function by selective AV nodal artery ethanol infusion.

Wang PJ, Ursell PC, Sosa-Suarez G, Okishige K, Friedman PL.

Pacing Clin Electrophysiol. 1992 May;15(5):779-89.

PMID:
1382281
10.

Modification of human atrioventricular nodal function by selective atrioventricular nodal artery catheterization.

Wang PJ, Sosa-Suarez G, Friedman PL.

Circulation. 1990 Sep;82(3):817-29.

PMID:
2394004

Supplemental Content

Loading ...
Support Center